Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.

Lupus - 1 Jan 2004

Diz-Kucukkaya R, Hancer V S, Inanc M, Nalcaci M, Pekcelen Y

Abstract excerpt

The effect of thrombophilic mutations in the development of thrombosis in patients with antiphospholipid syndrome (APS) has been extensively investigated. Factor XIII (FXIII) Val34Leu polymorphism is a newly described polymorphism which is located in the three amino acids away from the thrombin a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Antiphospholipid Syndrome
Share to Factor XIII

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genotype

Share to Leucine

Share to Polymorphism, Genetic

Share to Venous Thrombosis

Source

Identifiers

PMID: 14870915
DOI: 10.1191/0961203304lu479oa

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14870915-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.PMID 14870915Read ↗

Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.Semantic proximity Read ↗

Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.Semantic proximity Read ↗

Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.Semantic proximity Read ↗

Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.Semantic proximity Read ↗

Factor XIII Val34Leu and the risk of venous thromboembolism in factor V Leiden carriers.Semantic proximity Read ↗

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.Semantic proximity Read ↗

The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.Semantic proximity Read ↗

The FXIII Val34Leu polymorphism in venous and arterial thromboembolism.Semantic proximity Read ↗

Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.Semantic proximity Read ↗

Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?Semantic proximity Read ↗

The Val34Leu genetic variation in the A subunit of coagulation factor XIII in recurrent spontaneous abortion.Semantic proximity Read ↗

The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.